ENTX

Entera Bio Ltd.

Latest Form 4:Purchase$26KbyGermano Geno J (Director) · filed Mar 11, 2026

Entera Bio Ltd. (ENTX) has 13 SEC Form 4 filings (14 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Aug 7, 2026.

Insiders have net bought $102K over the trailing 6 months.

  • Industry:Biotechnology
  • CEO:Miranda J. Toledano
  • Employees:22
  • HQ:Jerusalem, JM, IL
  • IPO:2018-06-28

Insider Buying

$102K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Unique Insiders

3

in the rolling window

Market Cap

$147.7M

latest known value

Source
Purchase$26KMar 11SEC ↗
Purchase$12KMar 9SEC ↗
Ellis SeanFirst filing
Purchase$22KFeb 11SEC ↗
Taitel HayaFirst filing
Purchase$11KFeb 11SEC ↗
Germano Geno JFirst filing
Purchase$30KFeb 11SEC ↗

Related companies

Entera Bio Ltd. is in the Healthcare sector.